首站-论文投稿智能助手
典型文献
The S100 calcium binding protein A11 promotes liver fibrogenesis by targeting TGF-β signaling
文献摘要:
Liver fibrosis is a key transformation stage and also a reversible pathological process in various types of chronic liver diseases.However,the pathogenesis of liver fibrosis still remains elusive.Here,we report that the calcium binding protein A11(S100A11)is consistently upregulated in the integrated data from GSE liver fibrosis and tree shrew liver proteomics.S1 00A11 is also experimentally activated in liver fibrosis in mouse,rat,tree shrew,and human with liver fibrosis.While overexpression of S100A11 in vivo and in vitro exac-erbates liver fibrosis,the inhibition of S100A11 improves liver fibrosis.Mechanistically,S100A11 activates hepatic stellate cells(HSCs)and the fibrogenesis process via the regulation of the deacetylation of Smad3 in the TGF-β signaling pathway.S100A11 physically interacts with SIRT6,a deacetylase of Smad2/3,which may competitively inhibit the interaction between SIRT6 and Smad2/3.The subsequent release and acti-vation of Smad2/3 promote the activation of HSCs and fibrogenesis.Additionally,a significant elevation of S100A11 in serum is observed in clinical patients.Our study uncovers S100A11 as a novel profibrogenic factor in liver fibrosis,which may represent both a potential biomarker and a promising therapy target for treating liver fibrosis and fibrosis-related liver diseases.
文献关键词:
作者姓名:
Tingting Zhu;Linqiang Zhang;Chengbin Li;Xiaoqiong Tan;Jing Liu;Huiqin Li;Qijing Fan;Zhiguo Zhang;Mingfeng Zhan;Lin Fu;Jinbo Luo;Jiawei Geng;Yingjie Wu;Xiaoju Zou;Bin Liang
作者机构:
Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences&Yunnan Province,Kunming Institute of Zoology,Chinese Academy of Sciences,Kunming,Yunnan 650223,China;Kunming College of Life Science,University of Chinese Academy of Sciences,Kunming,Yunnan 650204,China;Center for Life Sciences,School of Life Sciences,Yunnan University,Kunming,Yunnan 650091,China;School of Traditional Chinese Medicine,Yunnan University of Chinese Medicine,Kunming,Yunnan 650500,China;Infectious Diseases Department and Hepatic Diseases Department,The First People's Hospital of Yunnan Province,Kunming,Yunnan 650034,China;Infectious Diseases Department and Hepatic Diseases Department,The Affiliated Hospital of Kunming University of Science and Technology,Kunming,Yunnan 650034,China;School of Laboratory Animal&Shandong Laboratory Animal Center,Science and Technology Innovation Center,Shandong First Medical University&Shandong Academy of Medical Sciences,Jinan,Shandong 250021,China;Institute for Genome Engineered Animal Models of Human Diseases,National Center of Genetically Engineered Animal Models for International Research,Liaoning Provence Key Lab of Genome Engineered Animal Models Dalian Medical University,Dalian,Liaoning 116044,China
文献出处:
引用格式:
[1]Tingting Zhu;Linqiang Zhang;Chengbin Li;Xiaoqiong Tan;Jing Liu;Huiqin Li;Qijing Fan;Zhiguo Zhang;Mingfeng Zhan;Lin Fu;Jinbo Luo;Jiawei Geng;Yingjie Wu;Xiaoju Zou;Bin Liang-.The S100 calcium binding protein A11 promotes liver fibrogenesis by targeting TGF-β signaling)[J].遗传学报,2022(04):338-349
A类:
S100A11,00A11,erbates,profibrogenic
B类:
calcium,binding,protein,promotes,liver,fibrogenesis,by,targeting,TGF,signaling,Liver,fibrosis,key,transformation,stage,also,reversible,pathological,process,various,types,chronic,diseases,However,pathogenesis,still,remains,elusive,Here,report,that,consistently,upregulated,integrated,data,from,GSE,tree,shrew,proteomics,experimentally,activated,mouse,human,While,overexpression,vivo,vitro,exac,inhibition,improves,Mechanistically,activates,hepatic,stellate,cells,HSCs,via,regulation,deacetylation,Smad3,pathway,physically,interacts,SIRT6,deacetylase,Smad2,which,may,competitively,interaction,between,subsequent,release,activation,Additionally,significant,elevation,serum,observed,clinical,patients,Our,study,uncovers,novel,represent,both,potential,biomarker,promising,therapy,treating,related
AB值:
0.506231
相似文献
Genome-wide CRISPR screen identifies synthetic lethality between DOCK1 inhibition and metformin in liver cancer
Junru Feng;Hui Lu;Wenhao Ma;Wenjing Tian;Zhuan Lu;Hongying Yang;Yongping Cai;Pengfei Cai;Yuchen Sun;Zilong Zhou;Jiaqian Feng;Jiazhong Deng;Ying Shu;Kun Qu;Weidong Jia;Ping Gao;Huafeng Zhang-Anhui Key Laboratory of Hepatopancreatobiliary Surgery,Department of General Surgery,Anhui Provincial Hospital,The First Affiliated Hospital of USTC,Division of Life Science and Medicine,University of Science and Technology of China,Hefei 230027,China;Hefei National Laboratory for Physical Sciences at Microscale,The Chinese Academy of Sciences Key Laboratory of Innate Immunity and Chronic Disease,School of Basic Medical Sciences,Division of Life Science and Medicine,University of Science and Technology of China,Hefei 230027,China;Shenzhen People's Hospital,Second Clinical Medical College of Jinan University,First Affiliated Hospital of Southern University of Science and Technology,Shenzhen 518000,China;Department of Pathology,School of Medicine,Anhui Medical University,Hefei 230032,China;School of Medicine and Institutes for Life Sciences,South China University of Technology,Guangzhou 510006,China
Macrophage polarization is involved in liver fibrosis induced by β1-adrenoceptor autoantibody
Ye Wu;Xiongxiong Fan;Haicun Yu;Jingyi Liu;Yanru Duan;Suli Zhang;Li Yan;Yunhui Du;Huirong Liu-Department of Physiology and Pathophysiology,School of Basic Medical Sciences,Capital Medical University,Beijing 100069,China;Beijing key laboratory of metabolic disorder related cardiovascular disease,School of Basic Medical Sciences,Capital Medical University,Beijing 100069,China;Zhengzhou Central Hospital affiliated of Zhengzhou University,Zhengzhou 450000,China;Shanxi Cardiovascular Hospital,Cardiac Care Unit,Taiyuan 030024,China;Department of Pathophysiology,Institute of Basic Medical Science,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100005,China;Beijing Anzhen Hospital,Capital Medical University,Beijing Institute of Heart,Lung and Blood Vessel Diseases,Beijing100029,China
Inhibition of ASCT2 induces hepatic stellate cell senescence with modified proinflammatory secretome through an IL-1α/NF-κB feedback pathway to inhibit liver fibrosis
Feixia Wang;Zhanghao Li;Li Chen;Ting Yang;Baoyu Liang;Zili Zhang;Jiangjuan Shao;Xuefen Xu;Guoping Yin;Shijun Wang;Hai Ding;Feng Zhang;Shizhong Zheng-Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica,School of Pharmacy,Nanjing University of Chinese Medicine,Nanjing 210023,China;Department of Anesthesiology,Nanjing Hospital Affiliated to Nanjing University of Chinese Medicine,Nanjing 210003,China;College of Traditional Chinese Medicine,Shandong University of Traditional Chinese Medicine,Jinan 250035,China;Department of General Surgery,Nanjing Hospital Affiliated to Nanjing University of Chinese Medicine,Nanjing 210003,China
Targeting a novel inducible GPX4 alternative isoform to alleviate ferroptosis and treat metabolic-associated fatty liver disease
Jie Tong;Dongjie Li;Hongbo Meng;Diyang Sun;Xiuting Lan;Min Ni;Jiawei Ma;Feiyan Zeng;Sijia Sun;Jiangtao Fu;Guoqiang Li;Qingxin Ji;Guoyan Zhang;Qirui Shen;Yuanyuan Wang;Jiahui Zhu;Yi Zhao;Xujie Wang;Yi Liu;Shenxi Ouyang;Chunquan Sheng;Fuming Shen;Pei Wang-Department of Pharmacy,Shanghai Tenth People's Hospital,Tongji University School of Medicine,Shanghai 200072,China;Institute of Nuclear Medicine,Tongji University School of Medicine,Shanghai 200072,China;Department of General Surgery,Shanghai Tenth People's Hospital,Tongji University School of Medicine,Shanghai 200072,China;Department of Pharmacology,School of Pharmacy,Naval Medical University/Second Military Medical University,Shanghai 200433,China;Department of Pharmacy,Shanghai Fourth People's Hospital,Tongji University School of Medicine,Shanghai 200081,China;Shanghai Key Laboratory of Regulatory Biology,Institute of Biomedical Sciences and School of Life Sciences,East China Normal University,Shanghai 200241,China;Chemical Biology Research Center School of Pharmaceutical Sciences,Wenzhou Medical University,Wenzhou 325000,China;Department of Medicinal Chemistry,School of Pharmacy,Naval Medical University/Second Military Medical University,Shanghai 200433,China
NFAT inhibitor 11R-VIVIT ameliorates mouse renal fibrosis after ischemia-reperfusion-induced acute kidney injury
Zhi-yong Xie;Wei Dong;Li Zhang;Meng-jie Wang;Zhen-meng Xiao;Yu-hua Zhang;Wan-xin Shi;Ying Huang;Yan Yang;Cui-li Li;Lei Fu;Xing-chen Zhao;Rui-zhao Li;Zhi-lian Li;Yuan-han Chen;Zhi-ming Ye;Shuang-xin Liu;Zheng Dong;Xin-ling Liang-The Second School of Clinical Medicine,Southern Medical University,Guangzhou 510515,China;Division of Nephrology,Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences,Guangzhou 510080,China;School of Medicine,South China University of Technology,Guangzhou 510006,China;Department of Cellular Biology and Anatomy,Medical College of Georgia at Augusta University,Augusta,GA,USA;Department of Medical Research,Charlie Norwood Veterans Affairs Medical Center,Augusta,GA,USA
IMM-H007 attenuates isoprenaline-induced cardiac fibrosis through targeting TGFβ1 signaling pathway
Shuai-xing Wang;Ye-nan Feng;Shan Feng;Ji-min Wu;Mi Zhang;Wen-li Xu;You-yi Zhang;Hai-bo Zhu;Han Xiao;Er-dan Dong-Department of Cardiology and Institute of Vascular Medicine,Peking University Third Hospital,NHC Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides,Key Laboratory of Molecular Cardiovascular Science,Ministry of Education,Beijing Key Laboratory of Cardiovascular Receptors Research,Beijing 100191,China;State Key Laboratory for Bioactive Substances and Functions of Natural Medicines,Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China
Platelet CFTR inhibition enhances arterial thrombosis via increasing intracellular Cl-concentration and activation of SGK1 signaling pathway
Han-yan Yang;Chao Zhang;Liang Hu;Chang Liu;Ni Pan;Mei Li;Hui Han;Yi Zhou;Jie Li;Li-yan Zhao;Yao-sheng Liu;Bing-zheng Luo;Xiong-qing Huang;Xiao-fei Lv;Zi-cheng Li;Jun Li;Zhi-hong Li;Ruo-mei Wang;Li Wang;Yong-yuan Guan;Can-zhao Liu;Bin Zhang;Guan-lei Wang-Department of Pharmacology,Zhongshan School of Medicine,Sun Yat-sen University,Guangzhou 510080,China;Academy of Integrative Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;institute of Pediatrics,Guangzhou Women and Children's Medical Center affiliated to Guangzhou Medical College,Guangzhou 510623,China;VIP Healthcare Center,the Third Affiliated Hospital of Sun Yat-sen University,Guangzhou 510630,China;Guangdong Cardiovascular Institute,Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences,Guangzhou 510080,China;Department of Anesthesiology,The Second Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou 510120,China;Department of Pharmacy,The First Affiliated Hospital of Sun Yat-sen University,Guangzhou 510080,China;Department of Anesthesiology,the First Affiliated Hospital,Sun Yat-sen University,Guangzhou 510080,China;School of Computer Science and Engineering,Sun Yat-sen University,Guangzhou 510006,China;Division of Biological Sciences,University of California,San Diego,La Jolla,CA,USA;Department of Cardiovascular Medicine,Translational Medicine Research Center,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China
Critical role of PAFR/YAP1 positive feedback loop in cardiac fibrosis
Tian-yu Li;Wei Su;Liang-liang Li;Xiao-guang Zhao;Na Yang;Jia-xin Gai;Xin Lv;Jing Zhang;Meng-qin Huang;Qing Zhang;Wei-hang Ji;Xiao-ying Song;Yu-hong Zhou;Xue-lian Li;Hong-li Shan;Hai-hai Liang-Department of Pharmacology(State-Province Key Laboratories of Biomedicine-Pharmaceutics of China,Key Laboratory of Cardiovascular Research,Ministry of Education),College of Pharmacy,Harbin Medical University,Harbin 150081,China;Zhuhai People's Hospital,Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment,Zhuhai Hospital Affiliated with Jinan University,Jinan University,Zhuhai 519000,China;Department of Cardiology,The Fourth Affiliated Hospital of Harbin Medical University,Harbin 150001,China;Shanghai Frontiers Science Research Center for Druggability of Cardiovascular Noncoding RNA,Institute for Frontier Medical Technology,Shanghai University of Engineering Science,Shanghai 201620,China;Research Unit of Noninfectious Chronic Diseases in Frigid Zone(2019RU070),Chinese Academy of Medical Sciences,Harbin 150081,China
Hepatocyte-derived VEGFA accelerates the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via activating hepatic stellate cells
Hao Shen;Han Yu;Qian-yu Li;Ya-ting Wei;Jing Fu;Hui Dong;Dan Cao;Lin-na Guo;Lei Chen;Yuan Yang;Ying Xu;Meng-chao Wu;Hong-yang Wang;Yao Chen-International Cooperation Laboratory on Signal Transduction,National Center for Liver Cancer,Ministry of Education Key Laboratory on signaling Regulation and Targeting Therapy of Liver Cancer,Shanghai Key Laboratory of Hepato-biliary Tumor Biology,Eastern Hepatobiliary Surgery Hospital,Second Military Medical University/NAVAL Medical University,Shanghai 200433,China;Department of Pathology,Shanghai Tenth People's Hospital,Tongji University School of Medicine,Shanghai 200072,China;Institute of Metabolism and Integrative Biology,Fudan University,Shanghai 200438,China;Third Department of Hepatic Surgery,Eastern Hepatobiliary Surgery Hospital,Second Military Medical University,Shanghai 200433,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。